Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Utilization of health services and prescription patterns among lupus patients followed by primary care physicians and rheumatologists in Puerto Rico.

Molina MJ, Mayor AM, Franco AE, Morell CA, López MA, Vilá LM.

Ethn Dis. 2008 Spring;18(2 Suppl 2):S2-205-10.

2.

Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico.

Molina MJ, Mayor AM, Franco AE, Morell CA, López MA, Vilá LM.

J Clin Rheumatol. 2007 Aug;13(4):202-4.

3.

Medicaid and access to care among persons with systemic lupus erythematosus.

Gillis JZ, Yazdany J, Trupin L, Julian L, Panopalis P, Criswell LA, Katz P, Yelin E.

Arthritis Rheum. 2007 May 15;57(4):601-7.

4.

Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus.

Yazdany J, Gillis JZ, Trupin L, Katz P, Panopalis P, Criswell LA, Yelin E.

Arthritis Rheum. 2007 May 15;57(4):593-600.

5.

Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations.

Vilá LM, Alarcón GS, McGwin G Jr, Friedman AW, Baethge BA, Bastian HM, Fessler BJ, Reveille JD; LUMINA Study Group..

Rheumatology (Oxford). 2004 Mar;43(3):358-63.

6.

Rheumatology practice profiles in teaching and community settings in Puerto Rico: implications to subspecialty training.

Negrón AM, Díaz-Correa LM, Gago R, Mayor AM, Martínez A, Vilá S, Vilá LM.

J Clin Rheumatol. 2013 Mar;19(2):67-71. doi: 10.1097/RHU.0b013e3182848037.

PMID:
23364661
7.

The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.

Ribi C, Trendelenburg M, Gayet-Ageron A, Cohen C, Dayer E, Eisenberger U, Hauser T, Hunziker T, Leimgruber A, Lindner G, Koenig K, Otto P, Spertini F, Stoll T, Von Kempis J, Chizzolini C; Swiss Systemic Lupus Erythematosus Cohort Study Group..

Swiss Med Wkly. 2014 Aug 7;144:w13990. doi: 10.4414/smw.2014.13990.

8.

Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012.

Piga M, Casula L, Perra D, Sanna S, Floris A, Antonelli A, Cauli A, Mathieu A.

Lupus. 2016 Jan;25(1):28-37. doi: 10.1177/0961203315596597.

PMID:
26199283
9.
10.

Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.

Suarez-Almazor ME, Gonzalez-Lopez L, Gamez-Nava JI, Belseck E, Kendall CJ, Davis P.

J Rheumatol. 1998 Oct;25(10):1980-5.

PMID:
9779854
11.

Differences between rheumatologists and other internists regarding diagnosis and treatment of systemic lupus erythematosus.

Lerang K, Gilboe IM, Gran JT.

Rheumatology (Oxford). 2012 Apr;51(4):663-9. doi: 10.1093/rheumatology/ker318.

12.

Disparities in asthma medication dispensing patterns: the case of pediatric asthma in Puerto Rico.

Vila D, Rand CS, Cabana MD, Quiñones A, Otero M, Gamache C, Ramírez R, García P, Canino G.

J Asthma. 2010 Dec;47(10):1136-41. doi: 10.3109/02770903.2010.517338.

13.

Clinical and prognostic value of autoantibodies in puerto Ricans with systemic lupus erythematosus.

Vilá LM, Molina MJ, Mayor AM, Peredo RA, Santaella ML, Vilá S.

Lupus. 2006;15(12):892-8.

PMID:
17211998
14.

[The prevalence of asthma and the utilization of medical services among those insured by a health-services company in Puerto Rico, 1996-1997].

Pérez-Perdomo R, Súarez-Pérez E, Torres D, Morell C.

Bol Asoc Med P R. 1999 Jul-Dec;91(7-12):91-7. Spanish.

PMID:
10842440
15.

Prevalence of diabetes mellitus among insured of a health insurance company in Puerto Rico: 1997-1998.

Pérez-Perdomo R, Pérez-Cardona C, Rodríguez-Lugo L.

P R Health Sci J. 2001 Jun;20(2):131-7.

PMID:
11561472
16.
17.

Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.

Zink A, Fischer-Betz R, Thiele K, Listing J, Huscher D, Gromnica-Ihle E, Specker C, Schneider M; German Collaborative Arthritis Centers..

Lupus. 2004;13(7):529-36.

PMID:
15352425
18.

Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.

Garris C, Jhingran P, Bass D, Engel-Nitz NM, Riedel A, Dennis G.

J Med Econ. 2013;16(5):667-77. doi: 10.3111/13696998.2013.778270.

PMID:
23425294
19.

Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual.

Vilá LM, Alarcón GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD; LUMINA Study Group..

J Rheumatol. 2005 Nov;32(11):2150-5.

PMID:
16265693
20.

Improving the prognosis of SLE without prescribing lupus drugs and the primary care paradox.

Wallace DJ.

Lupus. 2008 Feb;17(2):91-2. doi: 10.1177/0961203307086267.

PMID:
18250130
Items per page

Supplemental Content

Support Center